Pneumonia Testing Market Estimated to Reach $1,738 Million by 2023
Pneumonia is indicated as a complex infection, which affects the lower part of the respiratory tract along with deposition of cough in the lungs. It may even occur as a consequence to an upper tract infection. Frequently, it occurs in people with weakened immunity, and in geriatric population and children. Biotechnological methods can be approached for testing of pneumonia such as enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR). The global pneumonia testing market was valued at $932 million...
View full press release